// App-Quantinova.ai

67 : Melanin nanoparticles for safe and effective iron chelation therapy for Beta-thalassemia during pregnancy

Researchers

Presenter

  • Nahla Bakhamis

Principal Investigators

  • Helen Townley

Medical Centers

  • University of Oxford, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Ophthalmology (OP)

Disease

  • Beta-thalassemia

Biomarkers

  • N/A

Drug/Treatment

  • Phenazone

  • Dex-HEMA

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved